Meena Charan, MD
Family Practice · Camp Hill, PANPI 1538128418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $436, 2.4 times the $178 reported in 2019. Among family practice clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$471
- Lilly USA, LLC$244
- GSK$228
- AstraZeneca$219
- Novo Nordisk$157
- Amgen$140
- plus $838 from 17 others
What the payments were for
- Food & beverage$2,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $471 |
| Lilly USA, LLC | 14 | $244 |
| GSK | 14 | $228 |
| AstraZeneca | 14 | $219 |
| Novo Nordisk | 10 | $157 |
| Amgen | 9 | $140 |
| Pfizer | 8 | $128 |
| Boehringer Ingelheim | 7 | $124 |
| Merck | 7 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $107 |
| Paratek Pharmaceuticals, Inc. | 1 | $76 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Exact Sciences | 3 | $46 |
| Vertex | 1 | $33 |
| Novartis | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Bardy Diagnostics, Inc. | 1 | $10 |
How this compares
$2,296 in reported general payments places this provider in the 95th percentile of 870 family practice providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 77 | $95,186 |
| EliquisApixaban | 52 | $52,858 |
| JanuviaSitagliptin Phosphate | 31 | $27,553 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $21,624 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $17,000 |
| MyrbetriqMirabegron | 17 | $10,589 |
| Repatha SyringeEvolocumab | 11 | $8,257 |
| Atorvastatin Calcium | 500 | $7,310 |
| Rivastigmine | 12 | $3,162 |
| Metoprolol Succinate | 145 | $2,790 |
| Risedronate Sodium | 32 | $2,540 |
| Losartan Potassium | 180 | $2,471 |
| Esomeprazole Magnesium | 12 | $2,294 |
| Levothyroxine Sodium | 274 | $2,186 |
| Amlodipine Besylate | 286 | $2,095 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $124 | $95,18677 claims |
| PfizerEliquis | $128 | $52,85852 claims |
| MerckJanuvia, Janumet | $112 | $44,55342 claims |
| GSKTrelegy Ellipta | $228 | $21,62417 claims |
| AbbVieSynthroid | $471 | $1,81047 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 870 family practice providers in Pennsylvania.
Other family practice in Camp Hill
- Aaron ListopadWest Middlesex$1K
- Luna ChenElizabeth$1K
- Victoria McCarthyWillow Grove$933
- Kissa WalkerBensalem$535
- Caitlin SzczupakAltoona$384
- Rebecca RickardWilliamsport$309
- Christopher OlbrichPittsburgh$270
- Deborah SnyderHermitage$265
- Stephanie ArcherOakmont$225
- Lawrence JohnPittsburgh$214
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.